Chemveda Life Sciences - Walk-In Interviews for Multiple Positions on 30th Jan' 2021 - PHARMA WISDOM

Pharma, Life Science, Healthcare, Engineering Job Updates

Recent Updates

Monday, 25 January 2021

Chemveda Life Sciences - Walk-In Interviews for Multiple Positions on 30th Jan' 2021

Dear Candidate,

We are conducting Walk-In interview on 30th Jan 2021 for positions in Chemistry Services department .(CRO) .

Walk-In details :

Date & Time - 30 Jan 2021 (10 AM to 1 PM)
Venue : Chemveda Life Sciences, Plot#B-11/1, IDA Uppal, Hyderabad.

Job Description :
Position Name : Research Chemist / Research Associate

Department : Chemistry Services

Division : Synthesis

Qualification : M.Sc. (Organic chemistry/Medicinal Chemistry)

Experience : 1-3 years of relevant experience.

Work Location : Hyderabad

Key Skills and
Competencies :

  • Experience in Organic Synthesis/Multi-step Synthesis.
  • Handling reactions from mg to gram scale.
  • Sound Knowledge of isolation, separation & purifications techniques.
  • Experience in characterization and identification of Organic molecules using spectroscopy techniques like NMR, IR, LCMS, HPLC.
  • Positive and confident individual with strong work ethics.
  • Team player and good communications skills.

Kindly carry the below documents:
Updated Resume.
Last three months pay slips, recent hike letter. (Photocopy).
Passport size Photo.
1 photocopy of your Photo ID Proof (Pan Card/ Passport/ Drivers License).

Note :
Candidates need to have six months of a time gap between successive attempts of the interview.
Candidates who cannot attend the interview on the Walk-In date can forward the resume to

Candidates, who are not having CRO industry experience, can share their resume to

Required Candidate profile

Qualification: M.Sc (Organic Chemistry / Medicinal chemistry)
Experience: 1-3 years of relevant experience in Synthesis Chemistry from CRO Industry.

Join for Regular Job Updates in What's App  & Telegram

Thank You for Visiting
More Updates Visit daily @
Reach us on social media:

No comments:

Post a comment